A detailed history of Northeast Financial Consultants Inc transactions in Veru Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 16,300 shares of VERU stock, worth $11,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,300
Previous 16,300 -0.0%
Holding current value
$11,573
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.17 $63 - $111
95 Added 0.59%
16,300 $11,000
Q3 2022

Nov 15, 2022

BUY
$10.22 - $23.7 $165,615 - $384,058
16,205 New
16,205 $187,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.